LAIA GUARDIA ROCA

LAIA GUARDIA ROCA

orcid

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
26 March 2025 in Cancers
Verified
Journal Article
Open access
PDF file
BMBeatriz Merchán-Muñoz
Beatriz Merchán-Muñoz
MSMaría Suárez-Lledó
María Suárez-Lledó
LRLuis Gerardo Rodríguez-Lobato
Luis Gerardo Rodríguez-Lobato
Tommaso Francesco AielloTommaso Francesco Aiello
Tommaso Francesco Aiello
AGAntonio Gallardo-Pizarro
Antonio Gallardo-Pizarro
MSMaria Queralt Salas
Maria Queralt Salas
Background/Objectives: This study evaluated infectious complications and immune reconstitution in 253 adults undergoing peripheral blood allogeneic hematopoietic cell transplantation (allo-HCT) with post-transplant cyclophosphamide (PTCY)-based GVHD prophylaxis. Methods: Patients received grafts from HLA-matched donors (47.4%), mismatched unrelated donors (MMUD, 33.2%), or haploidentical donors (19.4%). Results: The estimated 2-year non-relapse mortality (NRM) was 11.8%, 26.4%, and 22.4%, respectively (p = 0.0528). The cumulative incidence (Cum.Inc) of acute and chronic GVHD, immunosuppression duration, and post-transplant outcomes were similar across donor types. The day +30 Cum.Inc of bacterial bloodstream infections (BSI) tended to be higher in HLA-matched transplants (49.2%, p = 0.073), while HHV-6 reactivation showed a trend toward higher frequency in haploidentical transplants (22.4%, p = 0.068). Cytomegalovirus (CMV) reactivation occurred between days +30 and +100, with the highest Cum.Inc in MMUD (59.5%, p = 0.033). BK virus-associated hemorrhagic cystitis showed a trend toward higher incidence in MMUD (22.3%, p = 0.056). Respiratory and fungal infections were most frequent in the first 100 days, with comparable rates across donor types. By day +180, most patients achieved immune reconstitution, with normalization of CD4+ T cells, CD8+ T cells, and IgG levels, independent of donor type. Conclusions: Patients undergoing allo-HCT with PTCY-based prophylaxis experience a high infectious density rate early post-transplant, which decreases after 6 months as immune reconstitution progresses, regardless of donor type.

21 October 2025 in Transplantation and Cellular Therapy
Verified
Journal Article
Closed access
FPFilipe R. Pinto
Filipe R. Pinto
MSMaría Queralt Salas
María Queralt Salas
MSMaría Suárez-Lledó
María Suárez-Lledó
APAlexandra Pedraza
Alexandra Pedraza
PCPaola Andrea Charry
Paola Andrea Charry
HBHOSPITAL CLINIC OF BARCELONA
HOSPITAL CLINIC OF BARCELONA

1 January 2025 in European Journal of Cancer Care
Verified
Journal Article
Open access
ARArianna Rosich-Soteras
Arianna Rosich-Soteras
CRCarla Ramos-Serrano
Carla Ramos-Serrano
ASAnna Serrahima-Mackay
Anna Serrahima-Mackay
CMCristina Gallego Miralles
Cristina Gallego Miralles
TMTeresa Solano Moliner
Teresa Solano Moliner
AZAdelaida Zabalegui
Adelaida Zabalegui
Introduction: Haematopoietic stem cell transplantation (HSCT) recipients and their caregivers may experience psychological distress. This study aimed to evaluate anxiety and depression in patients and caregivers throughout the HSCT process. As a secondary objective, we explored the association between anxiety and depression in patient and caregiver over the same period and compared anxiety and depression according to sociodemographic factors and whether HSCT was homebound or hospitalised. Methodology: Longitudinal descriptive study. Seventy‐two HSCT patients and their caregivers were consecutively included at a Spanish hospital between October 2019 and February 2021. The HADS instrument was used to assess anxiety and depression at six time‐points, including pre‐HSCT, the acute period and one‐year follow‐up. An adjusted linear mixed model assessed variable changes over time‐points and a correlational analysis evaluated the relationship between anxiety and depression. To detect differences between groups over time, a linear mixed model was adjusted. Results: Participants’ anxiety levels were high at all time‐points and consistently higher among caregivers than patients. Patients and caregivers’ depression levels were low pre‐HSCT and increased significantly during hospitalisation. Patients’ depression decreased during follow‐up but remained stable among caregivers. We observed moderate positive correlations between patient and caregiver anxiety or depression at all time‐points except pre‐HSCT. Caring for other dependents increased depression in patients and being female increased both anxiety and depression in caregivers. Residing in social housing increased patient anxiety and depression and caregiver depression. Conclusions: Diverging trajectories for patient and caregiver anxiety and depression were observed. Caregivers showed higher levels of anxiety than patients throughout the HSCT process and higher levels of depression from 3 months after HSCT. Admission was a critical time that increased depression in both. This study supports the need for new intervention approaches in prevention, early detection and treatment of anxiety and depression in patients receiving HSCT and their caregivers.

27 March 2026 in Blood Advances
Verified
Journal Article
Open access
RGRaquel Sarahí Salinas Gonzalez
Raquel Sarahí Salinas Gonzalez
LRLAIA GUARDIA ROCA
LAIA GUARDIA ROCA
BSBerta Solé
Berta Solé
CMCristina Moreno
Cristina Moreno
NLNoemi de Llobet
Noemi de Llobet
MSMaria Queralt Salas
Maria Queralt Salas
Frailty has emerged as a key component of allo-HCT candidate assessment and is closely associated with transplant outcomes. Exercise-based prehabilitation may improve transplant candidacy, yet real-world implementation is limited. Our institution implemented a structured Frailty Program (FP) to assess frailty and introduce prehabilitation interventions. This study describes the program’s evolution and evaluates the impact of prehabilitation. Between April 2021 and April 2025, 185 consecutive allo-HCT candidates were included in 3 sequential FP phases. In the first phase (No-Prehab, n = 76), patients underwent frailty assessment only. In the second phase (Pilot-Prehab, n = 59), patients received a home-based, nonsupervised prehabilitation program. In the third phase (Tele-Prehab, n = 50), patients participated in the HCT Pre-App Program, a structured digital telemedicine intervention supervised by rehabilitation physicians. Frailty was assessed at first consultation and HCT admission using the HCT Frailty Scale. Median prehabilitation duration was 6 weeks. Adherence was high across frailty groups (76%-88%), with no adverse events. Prehabilitation improved frailty status: fit patients increased from 22% to 42% in the Pilot-Prehab cohort (P = .009) and from 34% to 56% in the Tele-Prehab cohort (P = .001). Tele-Prehab independently increased the odds of being fit at admission (odds ratio [OR], 3.86; P = .001) and reduced frailty incidence (OR, 0.17; P = .031). One-year OS and NRM were comparable across cohorts (OS, 74.5%, 84.5%, and 78.1%; P = .367) with a trend toward lower NRM among prehabilitated patients (NRM, 14.6%, 5.1%, and 5.6%; P = .075). Frailty is dynamic in allo-HCT candidates, and results support how home-based digital prehabilitation improves fitness before transplantation.

25 December 2025 in Transplantation and Cellular Therapy
Verified
Journal Article
Open access
ATArnau Torrent-Rodríguez
Arnau Torrent-Rodríguez
ECEnric Cascos
Enric Cascos
ECEsther Carcelero
Esther Carcelero
RGRiu Gisela
Riu Gisela
IMInés Monge-Escartín
Inés Monge-Escartín
MSMaria Queralt Salas
Maria Queralt Salas
Early cardiac events (ECE) are a recognized cause of morbidity and mortality after allogeneic hematopoietic cell transplantation (allo-HCT), especially with the widespread use of post-transplant cyclophosphamide (PTCy) for graft-versus-host disease (GVHD) prophylaxis. Identifying patients at risk for ECE is crucial to optimize preventive strategies and improve outcomes. To validate the predictive performance of the CARE-BMT score for identifying patients at risk of ECE after allo-HCT and to determine whether incorporating PTCy exposure enhances its prognostic value. A retrospective cohort study including 593 adult patients who underwent allo-HCT between 2011 and 2023 at a single institution. ECE was defined as any new cardiac event within 100 days post-HCT. The CARE-BMT score-based on age, race, cardiac comorbidities, serum creatinine, triglyceride levels, and prior anthracycline exposure-was applied to stratify patients into intermediate- and high-risk groups. A modified-CARE-BMT score was developed by adding two points for standard-dose PTCy exposure. Survival analyses, cumulative incidence functions, and multivariate regression models were used to assess associations. ECE occurred in 47 patients (7.9%), with a median onset at 21 days post-HCT, and was associated with inferior one-year overall survival (48.6% vs. 75.0%, p<0.001). The CARE-BMT score stratified patients into intermediate- and high-risk groups with Day +100 ECE incidences of 5.8% and 11.2%, respectively (p=0.033). Standard-dose PTCy (50 mg/kg/day) was independently associated with increased ECE risk (p=0.014). The modified-CARE-BMT score stratified patients into low-, intermediate-, and high-risk groups with respective ECE incidences of 4.5%, 9.5%, and 12.7% (p=0.037). EASIX trajectories further supported the stratification capability of the modified model. The CARE-BMT score effectively predicts early cardiac events in allo-HCT recipients. Incorporating PTCy exposure into a modified risk model enhances its discriminatory power, allowing improved identification of high-risk patients who may benefit from tailored cardioprotective interventions and monitoring strategies.

19 April 2026 in Transplantation and Cellular Therapy
Verified
Journal Article
Open access
LCLaura Creus-Vilalta
Laura Creus-Vilalta
MSMaría Suárez-Lledó
María Suárez-Lledó
JMJulia Martinez-Sanchez
Julia Martinez-Sanchez
BMBlanca de Moner
Blanca de Moner
LRLAIA GUARDIA ROCA
LAIA GUARDIA ROCA
MSMaria Queralt Salas
Maria Queralt Salas
Hepatic sinusoidal obstruction syndrome (SOS) is a potentially life-threatening complication of allogeneic hematopoietic cell transplantation (allo-HCT) driven by endothelial injury. Post-transplant cyclophosphamide (PTCy) is widely used for graft-versus-host disease prophylaxis, but data on SOS incidence, risk factors, and outcomes in this setting are limited. The present study investigates the incidence and outcomes of SOS in adults undergoing allo-HCT with PTCy-based prophylaxis. This retrospective single-center study included 374 consecutive adult patients who underwent allo-HCT with PTCy between January 2014 and January 2025. SOS was diagnosed and graded according to established criteria. Endothelial activation was assessed using the Endothelial Activation and Stress Index (EASIX) at predefined peri-transplant time points. SOS occurred in 12 patients (3.2%), with a 100-day cumulative incidence of 2.7%. Six cases (50%) were moderate and six (50%) severe. Patients with myelofibrosis were markedly overrepresented (41.7% vs. 4.1%; P<0.001) and had an increased risk of SOS (HR 14.38, P<0.001). Median hospitalization was longer in SOS patients (46 vs. 29 days; P=0.01), and 16.6% required ICU admission. Ten patients (83.3%) received defibrotide and one underwent TIPS placement. Clinical response was observed in 91.7%, but seven patients (58.3%) died during follow-up, primarily from non-relapse mortality (NRM) (median 60 days). Two-year overall survival and NRM were 33.3% and 31.2% in SOS patients versus 71.8% and 12.6% in non-SOS patients. SOS was independently associated with higher NRM (HR 8.4, P<0.001) and inferior OS (HR 3.3, P=0.001). During the first 100 days, median EASIX values were higher in SOS patients. Higher log2-EASIX at pre-transplant evaluation (EASIX-PRE) and day 0 independently predicted SOS (HR 4.6; P=0.003). SOS remains an uncommon but clinically significant complication following allo-HCT with PTCy, substantially impacting survival. EASIX is a readily available biomarker that may enable early risk stratification and support individualized preventive strategies in this setting.